ID   HCA-1R
AC   CVCL_E2YA
RX   PubMed=24403450;
CC   Population: Japanese.
CC   Doubling time: 20 hours (PubMed=24403450).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2916 ! HCA1
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=24403450;
RA   Torii Y., Kato R., Minami Y., Hasegawa K., Fujii T., Udagawa Y.;
RT   "ERCC1 expression and chemosensitivity in uterine cervical
RT   adenocarcinoma cells.";
RL   Anticancer Res. 34:107-115(2014).
//